[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100520062":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":29,"centralContacts":34,"locations":44,"responsibleParty":100,"collaborators":102,"id":110,"slug":111,"hasResults":112,"nctId":113,"briefTitle":114,"officialTitle":115,"acronym":10,"eligibilityCriteria":116,"healthyVolunteers":112,"sex":117,"minAge":118,"maxAge":10,"enrollmentInfo":119,"targetDuration":10,"studyType":122,"phases":10,"briefSummary":123,"conditions":124,"keywords":10,"overallStatus":127,"whyStopped":10,"lastUpdateSubmitDate":128,"lastUpdatePostDateStruct":129,"startDateStruct":132,"completionDateStruct":134,"leadSponsor":136,"locationsCount":137},{"fullName":5,"class":6},"New Discovery LLC","INDUSTRY",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"iLivTouch then FibroScan",null,"Subjects in the Group \"iLivTouch then FibroScan\" will be measured using iLivTouch first and then FibroScan based on the randomization result.",[13,14],"Device: iLivTouch","Device: FibroScan",{"label":16,"type":10,"description":17,"interventionNames":18},"FibroScan then iLivTouch","Subjects in the Group \"FibroScan then iLivTouch\" will be measured using FibroScan first and then iLivTouch based on the randomization result.",[13,14],[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"DEVICE","iLivTouch","The examination with iLivTouch will be performed in each subject following the sequence determined by the randomization results.",[16,9],{"type":21,"name":26,"description":27,"armGroupLabels":28,"otherNames":10},"FibroScan","The examination with FibroScan will be performed in each subject following the sequence determined by the randomization results.",[16,9],[30],{"name":31,"affiliation":32,"role":33},"Calvin Q. Pan","NYU Langone Health","STUDY_CHAIR",[35,40],{"name":36,"role":37,"phone":38,"phoneExt":10,"email":39},"Calvin Q Pan, Dr","CONTACT","(718) 888-7728","Panc01@nyu.edu",{"name":41,"role":37,"phone":42,"phoneExt":10,"email":43},"Hector Ye, PA","17188880518","hector.ye.pa@gmail.com",[45,62,75,87],{"facility":46,"status":47,"city":48,"state":49,"zip":50,"country":51,"countryCode":52,"cosmosGeoPoint":53,"geoPoint":58,"contacts":59},"Stanford University","NOT_YET_RECRUITING","Redwood City","California","94305","United States","US",{"type":54,"coordinates":55},"Point",[56,57],-122.23635,37.48522,{"lat":57,"lon":56},[60],{"name":61,"role":37,"phone":10,"phoneExt":10,"email":10},"Ray Kim, Dr",{"facility":63,"status":47,"city":64,"state":65,"zip":66,"country":51,"countryCode":52,"cosmosGeoPoint":67,"geoPoint":71,"contacts":72},"Rush University","Chicago","Illinois","60612",{"type":54,"coordinates":68},[69,70],-87.65005,41.85003,{"lat":70,"lon":69},[73],{"name":74,"role":37,"phone":10,"phoneExt":10,"email":10},"Nancy Reau, Dr",{"facility":76,"status":77,"city":78,"state":78,"zip":79,"country":51,"countryCode":52,"cosmosGeoPoint":80,"geoPoint":84,"contacts":85},"NYU Langone","RECRUITING","New York","11355",{"type":54,"coordinates":81},[82,83],-74.00597,40.71427,{"lat":83,"lon":82},[86],{"name":36,"role":37,"phone":10,"phoneExt":10,"email":10},{"facility":88,"status":47,"city":89,"state":90,"zip":91,"country":51,"countryCode":52,"cosmosGeoPoint":92,"geoPoint":96,"contacts":97},"Baylor University","Houston","Texas","76798",{"type":54,"coordinates":93},[94,95],-95.36327,29.76328,{"lat":95,"lon":94},[98],{"name":99,"role":37,"phone":10,"phoneExt":10,"email":10},"Prasun K Jalal, Dr",{"type":101,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[103,105,106,107,108],{"name":32,"class":104},"OTHER",{"name":46,"class":104},{"name":63,"class":104},{"name":88,"class":104},{"name":109,"class":6},"Wuxi Hisky Medical Technology Co Ltd","100520062","comparison-of-ilivtouch-and-fibroscan-for-the-assessment-of-liver-fibrosis-and-steatosis-in-adult-patients-in-the-us-100520062",false,"NCT06051669","Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the US","Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the US: A Multicenter, Cross-sectional, and Prospective Study","Inclusion Criteria:\n\n* a. Adults aged above 18 years old who have at least one indication for TE examination determined by the physicians;\n* b. Patients who have test results for platelet count, ALT, AST, globulin, HBA1c, and total bilirubin (TBIL) levels within 60 days;\n* c. Patients who are willing to participate in the clinical study and can sign ICF.\n\nExclusion Criteria:\n\n* a. Excessive drinking history within 90 days: For women-140 grams of alcohol per week or more; For men-210 grams of alcohol per week or more;\n* b. Patients with alanine aminotransferase (ALT) or aspartate aminotransferase AST \\>100 U\u002Fml (or 2.5 × upper limit of normal (ULN) and\u002For total bilirubin (TBIL) \\> 1.8 mg\u002Fd (or \\>1.5 × ULN =1.2 mg\u002Fd);\n* c. Patients with a history or current evidence of decompensated liver cirrhosis;\n* d. Patients with various space-occupying tumors and cysts in the right liver;\n* e. Patients with other serious systemically diseases or a history of malignant tumors;\n* f. Patients with ascites;\n* g. Patients with a non-healing wound on the right upper abdomen at this moment;\n* h. Patients with intracavitary implantation of instruments;\n* i. Pregnant women (urine pregnancy test should be performed for all women with child-bearing potential during screening);\n* j. Any history of organ transplantation and existing functional grafts (except corneal or hair transplantation);\n* k. Lack of or limited legal capacity.","ALL","18 Years",{"count":120,"type":121},418,"ESTIMATED","OBSERVATIONAL","This is a multi-center, cross-sectional, and prospective study that will recruit patients from multiple hospitals or outpatient clinics in the USA to the comparison of iLivTouch and FibroScan for the assessment of liver fibrosis and steatosis in adult patients.",[125,126],"Liver Fibrosis","Fatty Liver","UNKNOWN","2023-10-11",{"date":130,"type":131},"2023-10-13","ACTUAL",{"date":133,"type":131},"2023-09-24",{"date":135,"type":121},"2025-03",{"name":5,"class":6},4]